1. Home
  2. TARS vs CAKE Comparison

TARS vs CAKE Comparison

Compare TARS & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • CAKE
  • Stock Information
  • Founded
  • TARS 2016
  • CAKE 1972
  • Country
  • TARS United States
  • CAKE United States
  • Employees
  • TARS N/A
  • CAKE 47900
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • CAKE Restaurants
  • Sector
  • TARS Health Care
  • CAKE Consumer Discretionary
  • Exchange
  • TARS Nasdaq
  • CAKE Nasdaq
  • Market Cap
  • TARS 1.8B
  • CAKE 2.5B
  • IPO Year
  • TARS 2020
  • CAKE 1992
  • Fundamental
  • Price
  • TARS $44.83
  • CAKE $48.06
  • Analyst Decision
  • TARS Strong Buy
  • CAKE Hold
  • Analyst Count
  • TARS 5
  • CAKE 14
  • Target Price
  • TARS $54.20
  • CAKE $44.31
  • AVG Volume (30 Days)
  • TARS 1.1M
  • CAKE 1.3M
  • Earning Date
  • TARS 11-13-2024
  • CAKE 10-29-2024
  • Dividend Yield
  • TARS N/A
  • CAKE 2.25%
  • EPS Growth
  • TARS N/A
  • CAKE 52.49
  • EPS
  • TARS N/A
  • CAKE 2.64
  • Revenue
  • TARS $129,621,000.00
  • CAKE $3,537,745,000.00
  • Revenue This Year
  • TARS $852.60
  • CAKE $5.97
  • Revenue Next Year
  • TARS $74.21
  • CAKE $5.40
  • P/E Ratio
  • TARS N/A
  • CAKE $18.22
  • Revenue Growth
  • TARS 801.96
  • CAKE 2.39
  • 52 Week Low
  • TARS $15.60
  • CAKE $30.96
  • 52 Week High
  • TARS $52.99
  • CAKE $50.75
  • Technical
  • Relative Strength Index (RSI)
  • TARS 57.98
  • CAKE 64.48
  • Support Level
  • TARS $46.22
  • CAKE $46.27
  • Resistance Level
  • TARS $52.99
  • CAKE $49.65
  • Average True Range (ATR)
  • TARS 3.62
  • CAKE 1.52
  • MACD
  • TARS -0.33
  • CAKE 0.09
  • Stochastic Oscillator
  • TARS 42.09
  • CAKE 66.25

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About CAKE Cheesecake Factory Incorporated (The)

Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.

Share on Social Networks: